Abivax S.A.
ABVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001956827
No open-market purchases or sales by Abivax S.A. insiders were filed in the last 90 days; 303 institutions reported holding it in 13F filings for Q2 2026, worth $7.18B in total; Maverick Capital is the only superinvestor holding it.
Other share classesAAVXF
13F holders, Q4 2024
Institutional positions in Abivax S.A. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +8 vs. Q3 2024
- Shares held
- 29.9M
- +2.48M (+9.0%) vs. Q3 2024
- Total value
- $218.6M
- −$94.3M (−30.1%) vs. Q3 2024
- New holders
- 14
- 14 more added
- Sold out
- 6
- 9 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 303 | $7.18B |
| Q1 2026 | 254 | $5.53B |
| Q4 2025 | 247 | $7.61B |
| Q3 2025 | 165 | $4.41B |
| Q2 2025 | 43 | $234.6M |
| Q1 2025 | 46 | $198.5M |
| Q4 2024 | 48 | $218.6M |
| Q3 2024 | 40 | $312.8M |
| Q2 2024 | 38 | $371.6M |
| Q1 2024 | 36 | $334.2M |
| Q4 2023 | 30 | $227.8M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Abivax S.A.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 6,056,596 | $44.3M | 4.33% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,579,209 | $26.2M | 0.98% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 2,130,000 | $15.6M | 0.86% | 00.0% | Unchanged |
| Great Point Partners LLC | 1,648,523 | $12.1M | 5.69% | −480,250−22.6% | Reduced |
| ADAR1 Capital Management, LLC | 1,513,393 | $11.1M | 2.28% | +991,781+190.1% | Added |
| Franklin Resources Inc | 1,466,062 | $10.7M | 0.00% | +141,710+10.7% | Added |
| Nantahala Capital Management, LLC | 1,436,047 | $10.5M | 0.74% | +450,413+45.7% | Added |
| VR Adviser, LLC | 1,345,780 | $9.85M | 0.68% | 00.0% | Unchanged |
| Commodore Capital LP | 1,284,110 | $9.40M | 0.69% | 00.0% | Unchanged |
| Blackstone Group Inc. | 936,607 | $6.86M | 0.03% | −585,827−38.5% | Reduced |
| Millennium Management LLC | 931,179 | $6.82M | 0.01% | +285,542+44.2% | Added |
| Citadel Advisors LLC | 855,676 | $6.26M | 0.01% | +389,247+83.5% | Added |
| Samsara BioCapital, LLC | 850,000 | $6.22M | 0.85% | 00.0% | Unchanged |
| Caligan Partners LP | 752,167 | $5.51M | 1.39% | +752,167 | New |
| JPMorgan Chase & Co | 728,919 | $5.34M | 0.00% | +728,919 | New |
| Saturn V Capital Management LLC | 653,071 | $4.78M | 1.87% | +5,052+0.8% | Added |
| Allostery Investments LP | 591,253 | $4.33M | 8.50% | +591,253 | New |
| Morgan Stanley | 479,326 | $3.51M | 0.00% | −25,426−5.0% | Reduced |
| Standard Life Aberdeen plc | 424,181 | $3.11M | 0.01% | +107,750+34.1% | Added |
| Boothbay Fund Management, LLC | 406,903 | $2.98M | 0.09% | +406,903 | New |
| Walleye Capital LLC | 302,642 | $2.22M | 0.02% | +45,225+17.6% | Added |
| Silverarc Capital Management, LLC | 285,120 | $2.09M | 0.47% | −176,540−38.2% | Reduced |
| Kennedy Capital Management, Inc. | 225,470 | $1.65M | 0.04% | +1,656+0.7% | Added |
| Springhill Fund Asset Management (HK) Co Ltd | 207,600 | $1.52M | 2.47% | +207,600 | New |
| UBS Group AG | 174,873 | $1.28M | 0.00% | +174,182+25,207.2% | Added |
| Soleus Capital Management, L.P. | 125,000 | $915.0K | 0.07% | 00.0% | Unchanged |
| Atika Capital Management LLC | 103,929 | $760.8K | 0.10% | −9,702−8.5% | Reduced |
| Point72 Asset Management, L.P. | 91,300 | $668.3K | 0.00% | −451,600−83.2% | Reduced |
| Shay Capital LLC | 50,029 | $366.2K | 0.09% | +50,029 | New |
| HighVista Strategies LLC | 49,064 | $359.1K | 0.13% | 00.0% | Unchanged |
| Woodline Partners LP | 48,136 | $352.4K | 0.00% | −33,594−41.1% | Reduced |
| Two Sigma Investments, LP | 19,736 | $144.5K | 0.00% | +19,736 | New |
| BNP Paribas Arbitrage, SA | 19,244 | $140.9K | 0.00% | +6,200+47.5% | Added |
| Geode Capital Management, LLC | 16,749 | $122.6K | 0.00% | +1,177+7.6% | Added |
| Stonepine Capital Management, LLC | 15,000 | $109.8K | 0.09% | +15,000 | New |
| Guggenheim Capital LLC | 12,512 | $91.6K | 0.00% | +12,512 | New |
| Ameriprise Financial Inc | 11,668 | $85.4K | 0.00% | +11,668 | New |
| HighTower Advisors, LLC | 10,000 | $73.2K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 7,557 | $55.3K | 0.00% | −8,896−54.1% | Reduced |
| Bank of America Corp | 5,536 | $40.5K | 0.00% | +1,990+56.1% | Added |
| R Squared Ltd | 4,950 | $36.2K | 0.04% | +4,950 | New |
| GAMMA Investing LLC | 3,976 | $29.1K | 0.00% | +3,976 | New |
| Barclays PLC | 1,095 | $8.02K | 0.00% | +1,095 | New |
| Rhumbline Advisers | 706 | $5.17K | 0.00% | +22+3.2% | Added |
| Financial Management Professionals, Inc. | 100 | $732 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 25 | $183 | 0.00% | −7−21.9% | Reduced |
| Principal Securities, Inc. | 10 | $73 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 37 | $0 | 0.00% | +37 | New |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −530,861−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −410,710−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −139,983−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −34,939−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −30,910−100.0% | Sold out |
| Caxton Corp | 0 | $0 | 0.00% | −11,365−100.0% | Sold out |